期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

增生性玻璃体视网膜病变的治疗进展 被引量：4

Treatment progress on proliferative vitreoretinopathy
下载PDF
导出
摘要 增生性玻璃体视网膜病变(proliferative vitreoretinopathy,PVR)描述孔源性视网膜脱离(rhegmatogenous retinal detachment,RRD)等疾病后玻璃体和/或视网膜表面特异细胞增殖形成纤维膜继而收缩、牵拉引起相关疾病的过程。玻璃体切割手术是目前临床治疗PVR的标准方法。基于对各种细胞和生长因子在PVR致病过程中作用的逐渐了解,涌现出很多新兴的药物治疗方法,主要包括抗炎药物、抗肿瘤药物和抗生长因子药物等。 Proliferative vitreoretinopathy （PVR） is a disease process that follows the proliferation of ectopic cell sheets in the vitreous and/or periretinal area, causing periretinal membrane formation, shrink and traction, in patients with rhegmatogenous retinal detachments. Pars plana vitrectomy is the standard treatment currently. There are many new drug therapies according to the functions of cytokines and growth factors in PVR, including anti- inflammatories, antineoplastic agents, antigrowth factors, and so on.
作者 王建伟 林铁柱 李世洋
机构地区 解放军第
出处 《国际眼科杂志》 CAS 2014年第2期263-265,共3页 International Eye Science
关键词 增生性玻璃体视网膜病变 视网膜脱离 生长因子 proliferative vitreoretinopathy retinaldetachment growth factor
分类号 R774.1 [医药卫生—眼科]
  • 相关文献

参考文献29

  • 1Cui J, Lei H, Samad A,et al. PDGF receptors are activated in human epiretinal membranes. Exp Eye Res 2009;88(3) :438-444 2.
  • 2Lei H, Hovland P, Velez G, et al . A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2007 ;48(5 ) :2335-2342 3.
  • 3Cassidy L, Barry P, Shaw C,et al . Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 1998 ;82(2) : 181-185 4.
  • 4Connor TB Jr, Roberts AB, Sporn MB, et al . Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989;83(5) :1661-1666 5.
  • 5Kon CH, Occleston NL, Aylward GW, et al. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci 1999 ;40(3 ) :705-712.
  • 6Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002 ;21 ( 1 ) : 127-144 7.
  • 7Hui YN, Liang HC, Cai YS, et al. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages. Graefes Arch Clin Exp Ophthalmol 1993 ;231 (2) : 109-114 8.
  • 8Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90(6) :810-816 9.
  • 9Rubsamen PE, Cousins SW. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy. Retina 1997;17(1) : 44-50 10.
  • 10Jonas JB, Hayler JK, Panda- Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000 ;84 (9) : 1064-1067 11.

同被引文献29

  • 1He S, Kumar SR, Zhou P, et al. Soluble EphB4 inhibition of PDGF- induced RPE migration in vitro [J]. Invest Ophthalmol Vis Sci, 2010,51(1) :543-552.
  • 2Jing Cui, Hetian Lei, Arif Samad, et al. PDGF Receptors Are Activated in Human Epiretinal Membranes[J]. Exp Eye Res, 2009,88(3) : 438-444.
  • 3Johnsen EO, Froen RC, Albert R,et al. Activation of neuralprogenitor cells in human eyes with proliferative vitreoretinopathy [J ]. Exp Eye Res, 2012,98 ( 1 ) : 28-36.
  • 4Innell SR, Martin GR. The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (a1lysine) by an extract from bone[J]. Proc Natl Acad Sci USA ,1968 ,61 (2) : 708-716.
  • 5Anirudh S, RobertJW , Abbot FC. Focus on molecules: Iysyl oxidase[J]. Exp Eye Res ,2012,104(2) :97-98.
  • 6Agre P. Aquaporin water channels[J] Biosci Rep, 2005 ,24 ( 3 ) : 127-163.
  • 7Saadoun S, Papadopoulos MC, Chikuma MH, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin-I gene disruption[J]. Nature ,2005,434(7034) : 786-792.
  • 8Chikuma MH. Verkman AS. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing[J] .J Mol Med (Bert) ,2008,86(2) :221-231.
  • 9Meng F, Rui YF. Xu L, Wan C, Li G. AQP-I enhances migration of bone marrow mesenchymal stem cells through regulation of FAK and beta-catenin[J]. Stem Cells Dev,2013 ,23 (I) :66-75.
  • 10Vogler S, Pannicke T, Hollborn M, Grosche A, Busch S, Hoffmann S,et at. MUlier cell reactivity in response to photoreceptor degeneration in ras with defective polycystin-2[J] . PLoS One, 2013,8(6) :61631.

引证文献4

二级引证文献2

国际眼科杂志
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部